Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes
Tools
Bhatti, M., Michail, O., Ayton, S., Gollop, N. D., Ryding, A., Rushworth, S., Bowles, K. and Flather, M. (2018) Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes. European Heart Journal, 39 (Supplement 1). p. 747. ISSN 0195-668X
Full text not available from this repository. (Request a copy)Item Type: | Article |
---|---|
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Depositing User: | LivePure Connector |
Date Deposited: | 06 May 2020 00:07 |
Last Modified: | 30 Sep 2021 14:54 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/75039 |
DOI: | 10.1093/eurheartj/ehy563.P3612 |
Actions (login required)
![]() |
View Item |